CTOs on the Move

Cardiology Consultants of Philadelphia

www.ccpdocs.com

 
As America’s largest independent cardiac care practice, CCP is home to the most experienced cardiologists in the Philadelphia region.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.ccpdocs.com
  • 207, North Broad Street
    Philadelphia, PA USA 19107
  • Phone: 215.227.3627

Executives

Name Title Contact Details

Similar Companies

MyDental360

MyDental360 - Know what matters. Find what works. Powered by Kulzer The information you want on the subjects that affect your everyday work. We cover them from every angle—in a concise view delivered right to your inbox. Your Benefits • Busine...

ChemBridge

ChemBridge, Corp. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AlliancePharma

The vision of AlliancePharma Inc. is to offer a service that is human, professional and personalized, and fosters the development of the skills of the replacement pharmacists and pharmacy technicians. In the long term, AlliancePharma Inc. strives to increase and improve the value of its privileged position in the area of pharmacy replacement services, as well as diversifying its activities in high value added sectors linked to health.

COMPASS Pathways

COMPASS is a mental health care company dedicated to accelerating patient access and experience to evidence-based innovation in mental health care.

Spectrum Pharmaceuticals

Spectrum`s core mission is to bring pharmaceutical products to patients for unmet medical needs. To this mission, we bring our years of drug development expertise, coupled with the insight of working in many different oncology indications. Spectrum and its subsidiaries have six marketed oncology/hematology products, three for different types of non-Hodgkins lymphoma, one for advanced metastatic colorectal cancer, one for a certain type of acute lymphoblastic leukemia (ALL) and one for multiple myeloma. There are two products in late-stage development, as well as a broad and diversified portfolio of proprietary drugs in various stages of development, all with a focus on oncology and hematology.